Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 10, 2005
The announcement was made by Jim Tobin, President and Chief Executive Officer, at the JPMorgan Healthcare Conference in San Francisco.
-
Jan 6, 2005
U.S. District Court in Delaware granted summary judgment of non-infringement in favor of Boston Scientific.
-
Jan 4, 2005
A live webcast and replay of the January 10th session will be available. Learn how to tune in for the presentation.
-
Dec 31, 2004
Jim Tobin, President and CEO, calls Company’s 2004 performance “nothing short of remarkable and speaks to a truly global effort."
-
Dec 30, 2004
Money is being directed to the Red Cross' International Response Fund.
-
Dec 20, 2004
Expansion of management structure is designed to position the Company for continued growth and success.
-
Dec 16, 2004
The transaction is expected to close early next year.
-
Dec 2, 2004
Motions for summary judgment were granted in part and denied in part.
-
Nov 24, 2004
A live webcast and replay of the December 1 conference session will be available.
-
Nov 23, 2004
An existing licensing agreement with Angiotech Pharmaceuticals, Inc. allows Company to obtain an exclusive license for the use of paclitaxel and other agents in the coronary vascular field.